Incremental dialysis in ESRD: systematic review and meta-analysis.

Abstract:

BACKGROUND:Incremental dialysis may preserve residual renal function and improve survival in comparison with full-dose dialysis; however, available evidence is limited. We therefore compared all-cause mortality and residual kidney function (RKF) loss in incremental and full-dose dialysis and time to full-dose dialysis in incremental hemodialysis (IHD) and incremental peritoneal dialysis (IPD). METHODS:We performed a systematic review and meta-analysis of cohort studies of adults with ESRD starting IHD and IPD. We identified in PubMed and Web of Science database all cohort studies evaluating incremental dialysis evaluating three outcomes: all-cause mortality, RKF loss, time to full dialysis. IPD was defined as < 3 daily dwells in Continuous Ambulatory Peritoneal Dialysis and < 5 sessions per week in Automated Peritoneal Dialysis, while IHD was defined as < 3 HD sessions per week. RESULTS:22 studies (75,292 participants), 15 in HD and 7 in PD, were analyzed. Mean age at dialysis start was 62 and 57 years in IHD and IPD subjects, respectively. When compared to full dose, incremental dialysis (IHD or IPD) had an overall mortality risk of 1.14 [95% CI 0.85-1.52] with high heterogeneity among studies (I2 86%, P < 0.001), and lower mean RKF loss (- 0.58 ml/min/months, 95% CI 0.16-1.01, P = 0.007). Overall, time to full-dose dialysis was 12.1 months (95% CI 9.8-14.3) with no difference between IHD and IPD (P = 0.217). CONCLUSIONS:Incremental dialysis allows longer preservation of RKF thus deferring full-dose dialysis, by about 1 year in HD and PD, with no increase in mortality risk. Large and adequate studies are needed to confirm these findings.

journal_name

J Nephrol

journal_title

Journal of nephrology

authors

Garofalo C,Borrelli S,De Stefano T,Provenzano M,Andreucci M,Cabiddu G,La Milia V,Vizzardi V,Sandrini M,Cancarini G,Cupisti A,Bellizzi V,Russo R,Chiodini P,Minutolo R,Conte G,De Nicola L

doi

10.1007/s40620-018-00577-9

subject

Has Abstract

pub_date

2019-10-01 00:00:00

pages

823-836

issue

5

eissn

1121-8428

issn

1724-6059

pii

10.1007/s40620-018-00577-9

journal_volume

32

pub_type

杂志文章,meta分析
  • Posttransplant recurrence of atypical hemolytic uremic syndrome.

    abstract::Hemolytic uremic syndrome (HUS) is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. It is usually secondary to infections by strains of Escherichia coli (STEC) that produce Shiga-like toxin. In about 10% of patients, no STEC infections are reported. In these ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000146

    authors: Valoti E,Alberti M,Noris M

    更新日期:2012-11-01 00:00:00

  • Na+:HCO3- cotransporters (NBC): expression and regulation in the kidney.

    abstract::Recent molecular cloning experiments have identified the existence of four NBC isoforms (NBC1, 2, 3 and 4) and two NBC-related proteins AE4 and NCBE (Anion Exchanger 4 and Sodium-dependent Chloride-Bicarbonate Exchanger). Except for AE4 which does not transport Na, all are presumed to mediate the cotransport of Na+ an...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Soleimani M

    更新日期:2002-03-01 00:00:00

  • Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD.

    abstract:BACKGROUND:The detailed mechanisms and treatment methods of chronic kidney disease (CKD) in patients with chronic heart failure (CHF) are not fully understood. We conducted a prospective study in CHF patients manifesting CKD to examine if AST-120 (Kremezin) improves cardiac and renal functions. METHODS:Twenty outpatie...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Shibahara H,Shibahara N

    更新日期:2010-09-01 00:00:00

  • Immunosuppressive treatment in primary focal segmental glomerulosclerosis.

    abstract:BACKGROUND:The therapeutic effects of immunosuppressive agents such as cyclosporin A, mycophenolate mofetil, rituximab and sirolimus on primary focal segmental glomerulosclerosis (FSGS) remain controversial. The present study was intended to review and analyze the treatment results of immunosuppressive agents for prima...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000092

    authors: Xu S,Xu G,Zeng L

    更新日期:2012-09-01 00:00:00

  • Endotoxin-induced acute renal failure in rats: effects of L-arginine and nitric oxide synthase inhibition on renal function.

    abstract:BACKGROUND:The regulation of renal hemodynamics is closely related to the L-arginine (L-Arg)/nitric oxide (NO) pathway. NO - metabolized from L-Arg - is capable of improving renal function in ischemic and toxic acute renal failure (ARF), while NO synthase (NOS) inhibition induces deterioration in renal function. The mo...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Schramm L,Weierich T,Heldbreder E,Zimmermann J,Netzer KO,Wanner C

    更新日期:2005-07-01 00:00:00

  • Identification of drug-related problems in ambulatory chronic kidney disease patients: a 6-month prospective study.

    abstract:BACKGROUND:Drug-related problems (DRPs) are common in chronic kidney disease (CKD) patients. We developed a 2-step consultation including a clinical pharmacist (CP) session and a nephrologist conventional care consultation to explore the feasibility of a pilot drug-oriented disease management program in controlling iat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.5000063

    authors: Belaiche S,Romanet T,Allenet B,Calop J,Zaoui P

    更新日期:2012-09-01 00:00:00

  • Wild-type uromodulin prevents NFkB activation in kidney cells, while mutant uromodulin, causing FJHU nephropathy, does not.

    abstract:BACKGROUND:Uromodulin (Tamm-Horsfall protein) is the most abundant urinary protein in healthy individuals. Despite 60 years of research, its physiological role remains rather elusive. Familial juvenile hyperuricemic nephropathy and medullary cystic kidney disease Type 2 are autosomal dominant tubulointerstitial nephrop...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-014-0079-7

    authors: Dinour D,Ganon L,Nomy LI,Ron R,Holtzman EJ

    更新日期:2014-06-01 00:00:00

  • Sodium removal and plasma tonicity balance are not different in hemodialysis and hemodiafiltration using high-flux membranes.

    abstract:BACKGROUND:The clinical benefits of on-line hemodiafiltration (HDF) versus high-flux membranes hemodialysis (hf-HD) are still debated. In fact, although a superiority of one treatment over the other, especially in terms of mortality, did not emerge from the analysis of clinical trials, improved intradialytic vascular s...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-018-00581-z

    authors: La Milia V,Ravasi C,Carfagna F,Alberghini E,Baragetti I,Buzzi L,Ferrario F,Furiani S,Barbone GS,Pontoriero G

    更新日期:2019-06-01 00:00:00

  • Necrotising, proliferative glomerulonephritis due to monoclonal cryoglobulinaemia.

    abstract::Renal involvement is uncommon in the rare condition of Type I cryoglobulinaemia. On review of the literature most cases featured membranoproliferative glomerulonephritis on renal biopsy. In this case report, we describe a presentation of rapidly progressive glomerulonephritis that histologically demonstrated necrotisi...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Boudville N,Walton J,House AA

    更新日期:2006-05-01 00:00:00

  • Lupus nephritis: an historical perspective 1968-1998.

    abstract::Lupus is now regarded as a syndrome which results from several related auto-immune processes, although the exact mechanisms of how the disease arises in susceptible individuals remain obscure. When the San Carlo meetings began in 1968, much less was known about the pathogenesis of autoimmunity, but the presence of aut...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Cameron JS

    更新日期:1999-07-01 00:00:00

  • Nephrolithiasis and hypertension: possible links and clinical implications.

    abstract::A definite epidemiological association exists between kidney stone disease and arterial hypertension, but the pathophysiological mechanisms are still not fully understood. Hypercalciuria or inflammation and oxidative stress have been proposed as possible links. However, there is more convincing evidence that the assoc...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-014-0068-x

    authors: Cupisti A,D'Alessandro C,Samoni S,Meola M,Egidi MF

    更新日期:2014-10-01 00:00:00

  • Normal fractional urate excretion identifies hyponatremic patients with reset osmostat.

    abstract:BACKGROUND:Reset osmostat (RO) occurs in 36% of patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH) and is not often considered when evaluating hyponatremic patients. Patients with RO are not usually treated, but recent awareness that symptoms are associated with mild hyponatremia creates a t...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.5301/jn.5000074

    authors: Imbriano LJ,Ilamathi E,Ali NM,Miyawaki N,Maesaka JK

    更新日期:2012-09-01 00:00:00

  • Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low.

    abstract:OBJECTIVE:It is uncertain whether increasing 25-hydroxyvitamin D (25-D) levels in chronic kidney disease (CKD) patients above those recommended by current guidelines result in progressive amelioration of secondary hyperparathyroidism. Our objective was to identify a potential therapeutic 25-D target which optimally low...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s40620-015-0186-0

    authors: Ennis JL,Worcester EM,Coe FL,Sprague SM

    更新日期:2016-02-01 00:00:00

  • Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier.

    abstract::The presence of circulating permeability factors (cPFs) has been hypothesized to be associated with recurrence of focal segmental glomerulosclerosis (rFSGS) in renal allografts. The available methods to detect cPFs are complex, not easily repeatable and inappropriate to represent the anatomical characteristics of the ...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-019-00683-2

    authors: Li M,Alfieri CM,Morello W,Cellesi F,Armelloni S,Mattinzoli D,Montini G,Messa P

    更新日期:2020-08-01 00:00:00

  • The role of pulse pressure in navigating the paradigm of chronic kidney disease progression in type 2 diabetes mellitus.

    abstract:BACKGROUND AND AIMS:Arterial stiffness is a risk factor for chronic kidney disease progression (CKD). Pulse pressure is a surrogate marker of arterial stiffness. It is unclear if pulse pressure predicts CKD progression in type 2 diabetes mellitus. METHODS:This was prospective study involving 1494 patients with estimat...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-020-00954-3

    authors: Low S,Moh A,Ang SF,Lim CL,Liu YL,Wang J,Ang K,Tang WE,Kwan PY,Lim Z,Subramaniam T,Sum CF,Lim SC

    更新日期:2021-01-25 00:00:00

  • Ischemic disease of the kidney: how and why to consider revascularization.

    abstract::With increasingly accurate non-invasive tests, the clinician frequently discovers obstruction of the renal arteries by atherosclerosis. The decision to reverse this obstruction is not straightforward, particularly when blood pressure can be easily controlled with medications. Proper management of this problem requires...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Middleton JP

    更新日期:1998-05-01 00:00:00

  • Chronic hypotension in the dialysis patient.

    abstract::Chronic hypotension, defined by a systolic blood pressure < 100 mmHg in the interdialytic period, affects 5-10% of hemodialysis patients, and is more prevalent among patients on long-term hemodialysis. This complication requires a substantial amount of medical and nursing care before and during dialysis to control its...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Cases A,Coll E

    更新日期:2002-07-01 00:00:00

  • Thin glomerular basement membrane disease.

    abstract::The term thin glomerular basement membrane disease (TBMD) refers to a condition characterised by thinning of the GBM at electron microscopy examination and, clinically, by isolated hematuria, frequently occurring in other family members, with no extra-renal manifestations. Progression towards chronic renal failure (CR...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Frascá GM,Onetti-Muda A,Renieri A

    更新日期:2000-01-01 00:00:00

  • Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.

    abstract:BACKGROUND AND OBJECTIVES:Peritonitis is the major cause of peritoneal dialysis (PD) technique failure. Prophylactic topical antibiotics have been reported to reduce peritoneal dialysis catheter exit site infections (ESI) and peritonitis rates. METHODS:We audited the effect of different exit site practices in the 12 P...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究

    doi:10.5301/jn.5000071

    authors: Davenport A,Pan Thames Renal Audit Peritoneal Dialysis Group.

    更新日期:2012-09-01 00:00:00

  • Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage.

    abstract::The pathogenetic role of adiponectin (ADPN) in kidney failure is not yet elucidated, since in vitro and in vivo studies have demonstrated that ADPN exerts both anti-inflammatory and pro-inflammatory effects. Starting from our previous findings demonstrating that HK-2 cells express and secrete ADPN, in this study we in...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-015-0220-2

    authors: Perri A,Vizza D,Lupinacci S,Toteda G,De Amicis F,Leone F,Gigliotti P,Lofaro D,La Russa A,Bonofiglio R

    更新日期:2016-04-01 00:00:00

  • Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.

    abstract:BACKGROUND:The recent multicenter, randomized, open-label INDEPENDENT study demonstrated that sevelamer improves survival in new to hemodialysis (HD) patients compared with calcium carbonate. The objective of this study was to determine the cost-effectiveness of sevelamer versus calcium carbonate for patients new to HD...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s40620-014-0122-8

    authors: Ruggeri M,Bellasi A,Cipriani F,Molony D,Bell C,Russo D,Di Iorio B

    更新日期:2015-10-01 00:00:00

  • Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options.

    abstract::Gonadal dysfunction is a frequent finding in men with chronic kidney disease and with end-stage renal disease. Testosterone deficiency, usually accompanied by elevation of serum gonadotropin concentrations, is present in 26-66% of men with different degrees of renal failure. Uremia-associated hypogonadism is multifact...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/JN.2011.8481

    authors: Iglesias P,Carrero JJ,Díez JJ

    更新日期:2012-01-01 00:00:00

  • Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations.

    abstract::Diabetic kidney disease (DKD) affects approximately one-third of patients with diabetes and taking into consideration the high cardiovascular risk burden associated to this condition a multifactorial therapeutic approach is traditionally recommended, in which glucose and blood pressure control play a central role. The...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.1007/s40620-020-00803-3

    authors: Leoncini G,Viazzi F,De Cosmo S,Russo G,Fioretto P,Pontremoli R

    更新日期:2020-10-01 00:00:00

  • Renal diseases in John Allen's 'Synopsis Universae Medicinae Practicae...'.

    abstract::John Allen, a British physician of the eighteenth century, deserves being remembered for a series of inventions, but most importantly -- from a 'medical' point of view -- for his highly praised manuscript, the 'Universae Medicinae Practicae,sive Doctissimorum Virorum de Morbis Eorumque Causis ac Remediis Judicia', whi...

    journal_title:Journal of nephrology

    pub_type: 传,历史文章,杂志文章

    doi:

    authors: Mezzogiorno A,Iorio L,Esposito A,Flamourakis M,Esposito V

    更新日期:2006-05-01 00:00:00

  • Effect of gender on various parameters of crush syndrome victims of the Marmara earthquake.

    abstract:BACKGROUND:Detailed analyses on crush syndrome resulting from earthquakes is scarce. This study aimed to analyze the effect of gender on clinical course of the renal victims of the catastrophic Marmara earthquake that struck Northwestern Turkey in 1999. METHODS:Questionnaires were prepared within the first week of dis...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Sever MS,Erek E,Vanholder R,Lameire N

    更新日期:2004-05-01 00:00:00

  • Proteinase 3/myeloblastin as a growth factor in human kidney cells.

    abstract:BACKGROUND:Numerous data support the possible role of myeloblastin/proteinase 3 (PR3) in growth and differentiation of neutrophil granulocytes and certain monocyte subtypes. However, whether PR3 is expressed in non-myeloid cells remains a matter of debate even though recent studies clearly demonstrated its expression i...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:

    authors: Relle M,Mayet WJ,Strand D,Brenner W,Galle PR,Schwarting A

    更新日期:2003-11-01 00:00:00

  • Treating anemia at different stages of renal disease.

    abstract::Cardiovascular disease is the leading cause of the poor long-term survival of patients with chronic kidney disease (CKD). Anemia, which is a frequent and early complication of CKD, not only impairs patients' quality of life, but also is an independent risk factor for adverse cardiovascular outcomes. This may be due to...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:

    authors: Locatelli F,Del Vecchio L,Pozzoni P

    更新日期:2007-11-01 00:00:00

  • Testing for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease.

    abstract:INTRODUCTION:Medullary cystic kidney disease type 1 (MCKD1; OMIM #174000) is a familial progressive tubule-interstitial nephropathy belonging to the recently defined group of autosomal dominant tubulointerstitial kidney diseases (ADTKD). CASE REPORT:A specific type of cytosine insertion in the extracellular variable n...

    journal_title:Journal of nephrology

    pub_type: 杂志文章

    doi:10.1007/s40620-016-0282-9

    authors: Musetti C,Babu D,Fusco I,Mellone S,Zonta A,Quaglia M,Cantaluppi V,Stratta P,Giordano M

    更新日期:2016-06-01 00:00:00

  • Ferumoxytol: a new era of iron deficiency anemia treatment for patients with chronic kidney disease.

    abstract::Ferumoxytol is a new product approved for intravenous use by the US Food and Drug Administration (FDA) in the treatment of iron deficiency anemia in adults with chronic kidney disease. This approval was based on data from 3 open-label, randomized, controlled clinical trials. In all of these trials, ferumoxytol was wel...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,评审

    doi:10.5301/jn.5000025

    authors: Kowalczyk M,Banach M,Rysz J

    更新日期:2011-11-01 00:00:00

  • Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial.

    abstract:BACKGROUND:Uremic pruritus as a symptom that affects hemodialysis (HD) patients can decrease the quality of life and increase morbidity in these patients. The aim of this study was to evaluate the effects of turmeric on uremic pruritus in HD patients. SUBJECTS AND METHODS:This was a double-blind placebo-controlled tri...

    journal_title:Journal of nephrology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s40620-014-0039-2

    authors: Pakfetrat M,Basiri F,Malekmakan L,Roozbeh J

    更新日期:2014-04-01 00:00:00